APAC Heart Valve Repair and Replacement Market- Industry Trends and Forecast to 2032
The Asia-Pacific heart valve repair and replacement market is expected to reach USD 3,057.50 million by 2031 from 1,330.73 million in 2024, growing with a substantial CAGR of 12.6% in the forecast period of 2024 to 2031.
Market SegmentationAsia-Pacific Heart Valve Repair And Replacement Market, By Product (Surgical Heart Valves Replacement, Surgical Heart Valves Repair, Tavi / Tavr Valves, Grafts, Patches, Medication, and Others), Procedure (Surgical Procedure and Non-Surgical Procedure), Indication (Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse, and Others), End User (Hospital, Specialty Centers, Cardiac Catheterization Lab, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (China, India, South Korea, Japan, Thailand, Australia, Singapore, Indonesia, Malaysia, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2031
Overview of Asia-Pacific Heart Valve Repair And Replacement Market Dynamics
Driver
• Rise in incidence of valvular heart defects
Restraint
• High cost associated with cardiovascular disease treatment
Opportunity
• Rise in demand for minimally invasive technology
Market PlayersSome of the key players operating in the Asia-Pacific heart valve repair and replacement market are:• MVRx, Inc.
• MeKo Laser Material Processing
• Comed B.V.
• CardiaMed
• Xeltis
• Foldax, Inc.
• JenaValve Technology, Inc.
• Colibri Heart Valve
• HLT, Inc.
• NeoChord, Inc.
• Meril Life Sciences Pvt. Ltd.
• Micro Interventional Devices, Inc.
• Biotronik
• Medtronic
• Abbott
• Neovasc Inc.
• Edwards Lifesciences Corporation
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.